Expert Review of Vaccines

Human versus HIV: round 2 defeat in AIDS vaccine development
pp. 151-153(3)
Author: Lu, Shan

CD4⁺ T-cell subsets: what really counts in preventing HIV disease?
pp. 155-158(4)
Authors: Mason, Rosemarie D; De Rose, Robert; Kent, Stephen J

New hope for prostate cancer patients
pp. 159-162(4)

Targeting mucosal dendritic cells with microbial antigens from probiotic lactic acid bacteria
pp. 163-174(12)
Authors: Mohamadzadeh, Mansour; Duong, Tri; Hoover, Timothy; Klaenhammer, Todd R

Current progress of DNA vaccine studies in humans
pp. 175-191(17)
Authors: Lu, Shan; Wang, Shixia; Grimes-Serrano, Jill M

Therapeutic vaccines against IgE-mediated allergies
pp. 193-208(16)
Author: Hellman, Lars

Current challenges in the development of vaccines for pneumonic plague
pp. 209-221(13)
Author: Smiley, Stephen T

Plasmodium falciparum malaria vaccines in development
pp. 223-240(18)
Authors: Vekemans, Johan; Ballou, W Ripley

Pandemic H5N1 influenza vaccine development: an update
pp. 241-247(7)
Authors: El Sahly, Hana M; Keitel, Wendy A

Influenza and respiratory syncytial virus in the elderly
pp. 249-258(10)
Authors: Elliot, Alex J; Fleming, Douglas M

Broadening inclusion of vulnerable populations in HIV vaccine trials
pp. 259-268(10)
Authors: Lau, Chuen-Yen; Cardinali, Massimo; Sato, Paul A; Fix, Alan; Flores, Jorge

Corrigendum
pp. 274-274(1)